Spermidine is a natural polyamine that induces autophagy through EP300 inhibition and eIF5A hypusination, and it extends lifespan across yeast, flies, worms and mice (about 10% in mice). Human evidence is early: small trials show cognitive and cardiovascular signals, and observational data link higher dietary intake to lower all-cause mortality. The catch is dose: a 2024 exploratory RCT found 40 mg/day barely moved circulating polyamine levels, so whether oral dosing raises tissue levels is unresolved.
Summary drafted from this entry’s sources; editorial review pending.
01Key questions
Does spermidine extend lifespan in humans?
Unknown. It extends lifespan about 10% in mice and more in flies and worms, with effects abolished in autophagy-deficient animals. All human evidence is surrogate endpoints or observational mortality associations; no human lifespan trial exists.34
Does spermidine help cognition?
Early signal only. The SmartAge trial in older adults with mild cognitive impairment showed a trend toward better MMSE scores and slower decline versus placebo, and a 2025 systematic review concluded human data show improved memory performance. The trials are small.2
How does spermidine work?
It induces autophagy by inhibiting the EP300 acetyltransferase and by driving eIF5A hypusination, an mTOR-independent route that may complement rapamycin rather than duplicate it.5
Do spermidine supplements raise polyamine levels?
Maybe not. An exploratory RCT found 40 mg/day produced minimal change in circulating polyamines in older men, leaving dose, tissue uptake and microbiome mediation as open questions. The 48-week POLYCAD trial finished recruiting in August 2025 and is the longest controlled human dosing study to date.11
Spermidine is a naturally occurring polyamine that induces autophagy — the cellular self-cleaning process critical for longevity. It extends lifespan in mice (~10%), improves cardiovascular aging, and shows promising signals for cognitive preservation in early human trials. Dietary spermidine intake correlates with reduced all-cause mortality in large epidemiological studies.
02What Is Spermidine?
Spermidine is a polyamine — a small organic molecule carrying multiple amine groups — found in all living cells. It was first isolated from semen (hence the name), but is abundant in many foods.
Core function relevant to aging: Spermidine is an endogenous inducer of autophagy — the process by which cells degrade and recycle damaged proteins, organelles, and aggregates. Autophagy declines with age, and restoring it is a validated longevity strategy across species. → See Autophagy
Other biological roles: - eIF5A hypusination — Spermidine is a precursor for hypusine, a modified amino acid essential for eIF5A, a translation factor critical for mitochondrial function and cellular proliferation - Nitric oxide synthase modulation — Indirect cardiovascular effects - Anti-inflammatory signaling — Reduces pro-inflammatory cytokine production - Chromatin remodeling — Modulates histone acetyltransferase activity (EP300 inhibition)
03The Science: Animal and Human Evidence
Lifespan Extension
| Model | Lifespan Effect | Reference |
|---|---|---|
| Yeast | ↑ Lifespan via enhanced autophagy | Madeo et al., 2009 (Nat Cell Biol) |
| Fruit flies | ↑ ~30% median lifespan | Eisenberg et al., 2009 |
| Nematodes (C. elegans) | ↑ ~15-25% lifespan | Eisenberg et al., 2009 |
| Mice | ↑ ~10% median lifespan (cardioprotective) | Eisenberg et al., 2016 (Nat Med) |
| Human cells | Delayed senescence markers in PBMCs | Eisenberg et al., 2009 |
Swipe table →
The Eisenberg et al. 2016 Nature Medicine study is the key animal paper: oral spermidine supplementation in aged mice: - ↑ Median lifespan by ~10% - Improved diastolic cardiac function - Enhanced cardiac autophagy - Reduced cardiac inflammation - Effects were autophagy-dependent (abolished in autophagy-deficient mice)
Mechanism: How Spermidine Induces Autophagy
Spermidine promotes autophagy through multiple converging mechanisms:
- EP300 inhibition — Spermidine inhibits EP300 (histone acetyltransferase), which normally acetylates and represses autophagy genes. Inhibiting EP300 de-represses autophagy gene transcription.
- eIF5A hypusination — Promotes translation of mitochondrial and autophagy-related proteins.
- mTOR-independent pathway — Unlike rapamycin, spermidine induces autophagy largely independent of mTOR → complementary mechanism → see mTOR and AMPK Pathways
- Reduced polyamine acetylation — Shifts cellular polyamine metabolism toward growth/autophagy balance.
Key insight: Spermidine and rapamycin induce autophagy through different mechanisms — making them potentially complementary rather than redundant. This has implications for combination longevity protocols.
04Human Clinical Evidence
Cardiovascular Aging
| Trial | Population | Intervention | Key Findings | Ref |
|---|---|---|---|---|
| BrACHOS | Adults with high CV risk | Wheat germ extract (spermidine-rich) × 3 years | Trend toward reduced major adverse CV events; anti-inflammatory effects | PMC8612618 |
| Cross-sectional (n>800) | Older adults | Dietary spermidine intake assessment | Higher intake associated with ↓ pulse wave velocity, ↓ systolic BP | Eisenberg et al., 2024 |
Swipe table →
Cognitive Aging — Most Promising Human Signal
| Trial | Population | Dose | Duration | Key Findings | Ref |
|---|---|---|---|---|---|
| SmartAge | Adults 60-96 with MCI | 3.3 mg/day spermidine | 12 months | Trend toward improved MMSE scores in completers; slower cognitive decline vs placebo | Pekar et al., 2025 |
| Cognitive cohort | Older adults | 1.2-3.3 mg/day | 12 months | ↑ MMSE (p<0.05); memory performance improved | Ageing Research Reviews, 2025 |
Swipe table →
Zou et al. 2025 (Ageing Research Reviews): Systematic review of spermidine's memory- and cognition-facilitating effects concluded: - Consistent cognitive benefits in aging animal models - Human data shows improved memory performance and slowed cognitive decline - Mechanism links to autophagy-mediated clearance of neurotoxic aggregates (amyloid-β, tau)
Epidemiological: Dietary Spermidine and Mortality
The BrACHOS-Diet study and related analyses found: - Higher dietary spermidine intake associated with reduced all-cause mortality in older adults - Each +0.1 mmol/day spermidine intake associated with HR ~0.85 for mortality - Effects mediated partly through cardiovascular protection
05Dietary Sources
Spermidine is naturally present in many foods, with widely varying concentrations:
| Food Category | Examples | Approximate Spermidine Content |
|---|---|---|
| Highest | Wheat germ, soybeans, mushrooms, aged cheese | 200-400 mg/kg |
| High | Green peas, broccoli, lentils, pear, mango | 60-150 mg/kg |
| Moderate | Rice, corn, chicken, beef | 20-60 mg/kg |
| Low | Fruits (most), vegetables (most), processed foods | <20 mg/kg |
Swipe table →
The Mediterranean diet — high in wheat germ, legumes, aged cheese, and vegetables — naturally provides high spermidine intake. This may partly explain the Mediterranean diet's longevity benefits.
06Supplementation
Uses
| Parameter | Detail |
|---|---|
| Bioavailability | Moderate — rapidly absorbed but short half-life (~2 hours) |
| Form | Spermidine (synthetic) or wheat germ extract (natural) |
| Timing | With meals (improves absorption) |
| Steady state | 4-6 weeks for tissue accumulation |
Swipe table →
Doses in studies
A critical caveat from Keohane et al. (Nutr Res, 2024): supplementation at 40 mg/day had minimal effects on circulating polyamine levels in older men in an exploratory RCT. This raises questions about: - Whether oral spermidine meaningfully changes tissue levels - Whether the the dose needs to be much higher - Whether dietary spermidine works through gut microbiome intermediaries rather than direct absorption
07Spermidine in the Longevity Context
| Comparison | Spermidine | Rapamycin | Fasting | Resveratrol |
|---|---|---|---|---|
| Autophagy mechanism | EP300 inhibition (mTOR-independent) | mTOR inhibition | mTOR + AMPK | Sirtuin activation |
| Lifespan in mice | ~10% | +14-26% | Moderate | Inconsistent |
| Human evidence | Cognitive, CV signals | PEARL trial | Strong metabolic data | Weak |
| Safety | Excellent | Immunosuppression risk | Safe | Generally good |
| Accessibility | OTC supplement | Prescription | Free | OTC |
| Best evidence | Cognitive aging, CV | Lifespan proxy | Metabolic health | None robust |
Swipe table →
Combination Logic
Spermidine may combine well with: - Rapamycin — Different autophagy induction mechanisms (mTOR-dependent vs independent) → see Metformin and Rapamycin - Caloric restriction — Spermidine may mimic some fasting effects on autophagy - Senolytics — Autophagy induction may complement senescent cell clearance - Taurine — Multi-target aging intervention; different mechanisms
08Limitations & Critical Analysis
What the Evidence Supports
- Strong mechanistic rationale — Autophagy decline is a validated aging hallmark; spermidine robustly induces autophagy
- Consistent animal data — Lifespan extension across yeast, flies, worms, and mice
- Encouraging human signals — Cognitive and cardiovascular markers in early trials
- Epidemiological consistency — Dietary intake inversely associated with mortality
What Remains Unproven
- No human lifespan trial — All human evidence is surrogate endpoints or observational
- Bioavailability uncertainty — The Keohane 2024 trial showed minimal circulating polyamine changes at 40 mg/day
- Small trial sizes — Most RCTs are <100 participants; SmartAge was 100 participants
- Cancer risk theoretical — Polyamines promote cell growth; long-term supplementation in cancer-prone populations is unstudied
092026 Update — New Evidence Landscape
Multi-Modal 2026 Reviews
- Blagojević BD, Brunel-Muguet S, Šućur R, et al. "The role of spermidine in plants and humans: a pathway from climate change adaptation to health benefits." npj Science of Food 10, 68 (2026). PMID: 41663409. Published 9 Feb 2026 (DOI 10.1038/s41538-025-00695-2). Cross-domain review linking plant polyamine biology, climate adaptation, food sources, and human aging. Particularly useful for the dietary-intake angle (Mediterranean-style diets, plant polyamine content, food-system leverage).
- Rzeski W, Rzeska W. "Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A." Nutrients 18(15):2511 (3 Aug 2026). DOI 10.3390/nu18152511. Positions spermidine alongside the other three senomorphic compounds against the López-Otín hallmarks framework — useful comparison block with Urolithin A - Mitophagy Inducer (already in library).
- Spermidine in the aging brain: mechanisms, preclinical and clinical insights. Mol Biol Rep (2026), DOI 10.1007/s11033-026-11827-6. Synthesizes brain-aging mechanisms (autophagy, mitophagy, neuroinflammation, mitochondrial Complex I) with 2024-2026 RCT data; cites Yan et al. Brain Res Bull 234:111711 (2026) on polyamine pathway in neurological disorders, and Adhikari & Saha Amino Acids 58(1):15 (2026) on probiotic-driven polyamine elevation as a neuroprotection axis.
POLYCAD — The First Long-Duration CV Outcome Trial
- POLYCAD trial (NCT06186102, "POLYamine treatment in elderly patients with Coronary Artery Disease"), Danish RCT, 24 mg/day high-purity spermidine trihydrochloride, n≈ participants, 48-week duration. Trial protocol: PMC 12574056 / Trials 2025. Recruitment completed August 2025; final study visit expected August 2026 — first read-out imminent and will set the new benchmark for human CV/CMet endpoint evidence in any non-diabetic CAD cohort.
- POLYCAD is not powered for mortality or major CV events (48 weeks is too short for hard endpoints), so even a positive result will be a surrogate/biomarker signal — but it establishes the longest controlled human dosing experience on record.
Mechanism Refinement (2025-2026)
- eIF5A hypusination in brain aging: the Liang et al. Cell Reports 2021 work (PMID 33852845) showed dietary spermidine reverses age-related decline in eIF5A hypusination and preserves mitochondrial respiration (especially Complex I) in aged fly/mouse brain. This mechanism — distinct from EP300/mTOR inhibition — explains the cognitive-aging signal seen in SmartAge and Pekar trials, and is reinforced by the 2026 Mol Biol Rep brain review.
Cancer Risk Update
No new clinical evidence of tumor acceleration from spermidine supplementation. The theoretical concern (polyamines as proliferation fuels) is unresolved but continues to be rated low-moderate in 2026 reviews — the long human dietary-exposure history (Mediterranean populations) and absence of signal in cohort studies argues against a major effect, but active-cancer supplementation remains unstudied and should default to caution.
Honest Position as of 2026-Q3
- Strongest human signals (2025-26): cognitive performance in older adults (SmartAge, Pekar 2025; cognitive cohort in Ageing Res Rev 2025; Gen Psychiatr 2025 observational).
- Standing caveats unchanged: no lifespan endpoint trial, dose-response unclear, bioavailability debate unresolved, cancer risk theoretical-only.
What studies and practitioners report
Amounts as reported in the cited sources: trial doses with the population studied, and practitioner-reported ranges marked as such. Not medical advice.
- Trial 0.9 mg/day · Spermidine from wheat germ (SmartAge) older adults with subjective cognitive decline, n=100 PMID 35616942
10Connections
11Sources
- PMC8612618PMC8612618
- Pekar T, et al. "Spermidine supplementation and cognitive performance in older adults (SmartAge)." 2025. PMC: PMC12519323PMC12519323
- Eisenberg T, et al. "Cardioprotection and lifespan extension by the natural polyamine spermidine." Nat Med . 2016;22(12):1428-1438. PMID: 27841876PubMed 27841876
- Eisenberg T, et al. "Induction of autophagy by spermidine promotes longevity." Nat Cell Biol . 2009;11(11):1305-1314. PMID: 19759650PubMed 19759650
- Liang Y, et al. "eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction." Cell Rep . 2021;35(5):108941. PMID: 33852845PubMed 33852845
- PubMed 41663409PubMed 41663409
- DOI 10.1038/s41538-025-00695-2DOI 10.1038/s41538-025-00695-2
- DOI 10.3390/nu18152511DOI 10.3390/nu18152511
- DOI 10.1007/s11033-026-11827-6DOI 10.1007/s11033-026-11827-6
- NCT06186102NCT06186102
- PMC12574056PMC12574056
12Entry history
Latest content update.
Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.